scieee Open visual document viewer

Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus

Reeves, Emer P.,Murphy, Thomas,Daly, Paul,Kavanagh, Kevin

Abstract

Exposure of the pulmonary pathogen Aspergillus fumigatus to amphotericin B alters membrane permeability as indicated by the escape of amino acids and protein from the mycelium. Amphotericin B exposure for periods of 2-4 h also leads to increased release of the immunosuppressive agent gliotoxin into the surrounding culture medium. Examination of the intracellular gliotoxin concentration following exposure to amphotericin B indicated elevated levels within the hyphae as well as in the culture medium - an effect which was also evident upon exposure of A. fumigatus to DMSO. These results indicate that in parallel with the ability of amphotericinBto act as a fungistatic agent it can also induce the synthesis of gliotoxin and facilitate its release by increasing the permeability of the fungal cell membrane. Increased synthesis of gliotoxin may result from the commencement of secondary metabolism in the presence of amphotericin B. The ability of amphotericin B to enhance the synthesis and release of gliotoxin may exacerbate the effects of the toxin and facilitate fungal invasion of pulmonary tissue.

Full text

Jou nal o Medical Mic obiology (2004), 53, 1–7 DOI 10.1099/jmm.0.45626-0 45626 &2004 SGM P in ed in G ea B i ain 1 Co espondence Ke in Ka anagh [email p o ec ed] Recei ed 5 Feb ua y 2004 Accep ed 29 Ap il 2004 Ampho e icin B enhances he syn hesis and elease o he immunosupp essi e agen glio oxin om he pulmona y pa hogen Aspe gillus umiga us Eme P. Ree es, Thomas Mu phy, Paul Daly and Ke in Ka anagh Medical Mycology Uni , Na ional Ins i u e o Cellula Bio echnology, Depa men o Biology, Na ional Uni e si y o I eland Maynoo h, Co. Kilda e, I eland Exposu e o he pulmona y pa hogen Aspe gillus umiga us o ampho e icin B al e s memb ane pe meabili y as indica ed by he escape o amino acids and p o ein om he mycelium. Ampho e icin B exposu e o pe iods o 2–4 h also leads o inc eased elease o he immunosupp essi e agen glio oxin in o he su ounding cul u e medium. Examina ion o he in acellula glio oxin concen a ion ollowing exposu e o ampho e icin B indica ed ele a ed le els wi hin he hyphae as well as in he cul u e medium – an e ec which was also e iden upon exposu e o A. umiga us o DMSO. These esul s indica e ha in pa allel wi h he abili y o ampho e icin B o ac as a ungis a ic agen i can also induce he syn hesis o glio oxin and acili a e i s elease by inc easing he pe meabili y o he ungal cell memb ane. Inc eased syn hesis o glio oxin may esul om he commencemen o seconda y me abolism in he p esence o ampho e icin B. The abili y o ampho e icin B o enhance he syn hesis and elease o glio oxin may exace ba e he e ec s o he oxin and acili a e ungal in asion o pulmona y issue. INTRODUCTION The ungus Aspe gillus umiga us is a pulmona y pa hogen capable o inducing disease in hose wi h p e-exis ing pulmona y mal unc ion (e.g. as hma, cys ic ib osis), disease (e.g. ube culosis, lung cance ) o unde going immuno- supp essi e he apy p io o o gan ansplan a ion (Denning, 1996a; F ase , 1993; Daly & Ka anagh, 2001). Th ee o ms o aspe gillosis a e ecognized clinically: sap o- phy ic, alle gic and in asi e. In asi e aspe gillosis (IA) is he mos se ious o m o disease as i in ol es he in asion o iable issue and may p oduce a mo ali y a e o 80–95 % (Denning, 1996b, 1998). IA has eme ged as an impo an disease in ecen decades due o he use o agg essi e immunosupp essi e he apy causing p olonged neu openia in he ea men o cance and leukaemia (Daly & Ka anagh, 2001). Despi e agg essi e an i- ungal chemo he apy, dea h due o IA usually esul s 7–14 days pos -diagnosis (Denning, 1996b). A. umiga us p oduces a ange o seconda y me aboli es such as glio oxin, hel olic acid and umagillin which may acili a e i s g ow h and pe sis ence in he lung (Ami ani e al., 1995a; Hogan e al., 1996). Ex ac s ob ained om spu um sols o pa ien s wi h aspe gillosis damage human espi a o y epi he- lial cells (Ami ani e al., 1995a). Subsequen analysis con- i med ha glio oxin de i ed om A. umiga us was he oxic agen and ha hel olic acid was also capable o comple e cilios asis and epi helial cell dis up ion (Ami ani e al., 1995b). Glio oxin (C13H14N2O4S2, molecula mass 326.4) is an epipoly hiodioxopipe azine (Wa ing & Bea e , 1996) which displays immunosupp essi e p ope ies in i o (Su on e al., 1994). Glio oxin is capable o inhibi ing mac ophage unc- ion and adhe ence o plas ic su aces (Be ou e al., 2002; Eichne e al., 1986) and may al e he immune esponse o Aspe gillus as i can induce apop o ic cell dea h in mac o- phages (Wa ing, 1990), cells o he spleen (B ai hwai e e al., 1987) and he immune sys em (Su on e al., 1994). The immunosupp essi e p ope ies o glio oxin ha e been e al- ua ed o supp essing he whole body immune esponse p io o o gan ansplan a ion (Su on e al., 1995). Glio oxin is also capable o inducing cell dea h in a mu ine ib oblas ic cell line (Pi a, 1994). Glio oxin has been de ec ed in samples om animals (Richa d & DeBey, 1995; Richa d e al., 1996) and humans (Shah e al., 1995) whe e i may acili a e ungal pe sis ence and coloniza ion o issue. In addi ion, glio oxin has been implica ed in he des uc ion o lung pa enchyma in IA (Su on e al., 1996) and he pene a ion o blood essels in angio-in asi e aspe gillosis (F ase , 1993) Con en ional he apy o he con ol o aspe gillosis elies upon he use o he polyene, ampho e icin B (Ellis, 2002) and he azoles, i aconazole and luconazole (Canu o & Rode o, 2002). Ampho e icin B displays ungis a ic ac i i y and unc ions by o ming ape u es in he cell memb ane, by A icle numbe = 45626 Doc opic is: pa h i Abb e ia ion: IA: In asi e aspe gillosis. complexing he memb ane s e ol, e gos e ol (Abu-Salah, 1996). Each po e consis s o an annulus o eigh ampho- e icin B molecules linked hyd ophobically o e gos e ol. The hyd oxyl esidues o he polyene d ug ace inwa ds o gi e an e ec i e po e diame e o 0.4–1.0 nm. Ampho e icin B– e gos e ol po es allow he exi o in acellula cons i uen s (e.g. ions and small molecula mass compounds) and he en y o hyd ogen ions leading o inc eased cy oplasmic acidi y (Cohen, 1998). While ampho e icin B can induce he o ma ion o ape u es in he ungal cell memb ane, he e ec may no be a al o he cell and ‘ eco e y’ may be possible (Liao e al., 1999). I has been es ablished ha while a speci ic concen a ion o ampho e icin B may inhibi eplica ion, as indica ed by lack o ungal g ow h, speci ic cellula unc ions (e.g. ans-memb ane po en ial, in acellula enzyme ac i i y and memb ane in eg i y) s ill ope a e and, o e ime, he ungus may esume he abili y o g ow and di ide (Liao e al., 1999). An al e na i e explana ion o he mode o ac ion o ampho- e icin B has ecen ly been p oposed and sugges s ha , in addi ion o he o ma ion o po es in he ungal cell memb ane, ampho e icin B also al e s he pe meabili y o he phospholipid bilaye by changing he memb ane phase, i.e. inc easing he luidi y o he bilaye (Venegas e al. 2003). Howe e , he dominan e ec o ampho e icin B appea s o be he o ma ion o po es in he memb ane by complexing e gos e ol. The abili y o ampho e icin B o induce he elease o in acellula cons i uen s in Candida albicans ia memb ane ape u es has been es ablished p e iously (Ghosh & Ghosh, 1963) and aises he possibili y o he elease o low molecula mass oxins om pa hogenic ungi. Consequen ly, he aim o his s udy was o es ablish whe he exposu e o A. umiga us o ampho e icin B could lead o he elease o a low molecula mass oxin such as glio oxin; a p ocess which could ha e he po en ial o exace ba e he immunosupp essi e and in asi e abili ies o A. umiga us. MATERIAL AND METHODS A. umiga us cul u e condi ions. A. umiga us ATCC 26933 (ob- ained om he Ame ican Type Cul u e Collec ion) was used in his s udy. Aspe gillus cul u es we e g own in minimal essen ial medium Eagle (MEM) (Sigma Ald ich) o RPMI medium supplemen ed wi h 5 % ( / ) e al cal se um (Sigma Ald ich) a 37 8C and 200 .p.m., o up o 4 days. S ocks we e main ained on mal ex ac aga (MEA) (Oxoid). E ec o ampho e icin B on g ow h o A. umiga us .MEA pla es con aining spo ula ing Aspe gillus colonies we e washed wi h 10 ml 0.1 % ( / ) Tween 80 (Me ck) in PBS (pH 7.2) (Sigma Ald ich) o isola e conidia. Conidia we e washed wice in s e ile PBS, cen i uged (1500 g, 5 min in a Beckman GS-6 cen i uge) and coun ed using an haemocy ome e . Flasks con aining MEM (25 ml) we e inocula ed wi h 13105Aspe gillus conidia o gi e a densi y o 4 3103ml1and incuba ed a 37 8C and 200 .p.m. Cul u es we e supplemen ed wi h ampho e icin B a inal concen a ions o 0.04, 0.08, 0.16 and 0.32 ìgml 1. Flasks we e emo ed a each ime poin and he con en s il e ed h ough a Wha man No. 1 il e in a Bu ¨chne unnel and ai - d ied. A g ow h cu e was cons uc ed o d y ungal biomass e sus incuba ion ime. E alua ion o memb ane leakage. Se en y- wo-hou -old cul u es (25 ml) o A. umiga us we e ha es ed by cen i uga ion (2056 g,20 min), washed h ee imes in PBS and he hyphal mass esuspended in 25 ml PBS. Ampho e icin B (0.04, 0.08, 0.16 o 0.32 ìgml 1) o DMSO (Sigma Ald ich) (0.5 % / ) was added and he cul u es incuba ed a 37 8C and 200 .p.m. o a u he 1, 2 o 4 h. A each ime poin a cul u e was emo ed and he con en s il e ed h ough a Wha man No. 1 il e . The il a e was passed h ough a 0.45 ìM sy inge il e (Sa o ius) and ee amino acids o p o ein we e measu ed as desc ibed below. Amino acid concen a ion was de e mined by he ninhyd in colo i- me ic me hod and is exp essed in e ms o aspa ic acid and glu amic acid, which we e used as s anda ds. A ninhyd in (Sigma Ald ich) solu ion (200 ìl; s ock: 0.35 g in 100 ml e hanol) was added o each sample (1 ml) and hea ed o 95 8C o 4 min. A e cooling o oom empe a u e in an ice ba h, he abso bance a 570 nm was eco ded on a spec opho ome e (Beckman DU 640). To de e mine he quan i y o p o ein eleased om he hyphal mass, samples we e assayed using he B ad o d eagen (Bio-Rad), wi h BSA (Sigma Ald ich) as s anda d. Ex ac ion o glio oxin om A. umiga us cul u e il a e. Hyphae o Aspe gillus we e emo ed om he MEM cul u e medium o RPMI medium by il a ion and an equal olume (25 ml) o chlo o o m (Hype Sol ; BDH) was added o he il a es. Following con inual mixing o 30 min, he chlo o o m ac ion was collec ed and e apo- a ed o d yness in a Bu ¨chi (B inkmann Ins umen s; Wes bu y, NY) o o e apo a o . D ied ex ac s we e dissol ed in 250 ìl me hanol (Hype Sol , BDH) and s o ed a 70 8C un il assayed. Ex ac ion o glio oxin om hyphae o A. umiga us .The ex ac ion o in acellula glio oxin om hyphae o A. umiga us was pe o med as ollows: hyphae we e eco e ed om MEM cul u e medium (50 ml) o RPMI medium (50 ml) by il a ion. Hyphae we e washed in PBS and g ound o a ine powde unde liquid N2using a p e-chilled pes le and mo a . The g ound hyphae we e esuspended in 10 ml 6 M HCl. Chlo o o m (50 ml) was added and he mix u e s i ed a oom empe a u e o 30 min. The sample was pou ed in o a sepa a ion unnel and he glio oxin ex ac ed in he lowe chlo o o m laye . Following chlo o o m e apo a ion, he d ied ex ac s we e dissol ed in 250 ìl me hanol and le els o glio oxin quan i ied by Re e sed Phase- HPLC. Quan i ica ion o glio oxin by HPLC. Glio oxin was de ec ed by Re e sed Phase-HPLC (Spec a-Physics). The mobile phase was 34.9% ( / ) ace oni ile (Hype Sol , BDH), 0.1 % ( / ) i luo oace ic acid (Sigma Ald ich) and 65 % ( / ) deionized-dis illed wa e . Glio oxin ex ac (20 ìl) was injec ed on o a C18 Hewle Packa d column. A s anda d cu e o peak a ea e sus glio oxin concen a ion was cons uc ed using glio oxin s anda ds (50, 100 and 200 ng ml1) dissol ed in me hanol (Sigma Ald ich). S a is ical analysis. All assays we e pe o med on h ee independen occasions. Resul s p esen ed a e he mean s anda d e o . S a is ical analysis we e pe o med using S uden ’s wo ailed - es wi h alues o P,0.05 conside ed s a is ically signi ican . E. P. Ree es and o he s 2 Jou nal o Medical Mic obiology 53 RESULTS The e ec o ampho e icin B on he g ow h o A. umiga us Cul u e medium was inocula ed wi h conidia o A. umiga us a an ini ial densi y o 4 3103ml1and incuba ed as desc ibed. An un ea ed cul u e and ou cul u es supple- men ed wi h di e en concen a ions o ampho e icin B we e used. The esul s (Fig. 1) indica e ha while he concen a ions o ampho e icin B employed he e ac as ungis a ic agen s o e he i s 24 h, he a e o g ow h o he cul u es supplemen ed wi h 0.04 and 0.08 ìg ampho- e icin B ml1is app oxima ely he same as he con ol o e he 24–72 h pe iod. Following 96 h incuba ion, he ea ed cul u es eached a mass o app oxima ely 65–70 % o ha o he con ol. This expe imen demons a ed ha he concen- a ions o ampho e icin B chosen o subsequen wo k we e ungis a ic a he han ungicidal, as used clinically (Liao e al., 1999). To e i y ha he ampho e icin B concen a ions employed in subsequen expe imen s we e ungis a ic a he han ungicidal, 48 h cul u es o A. umiga us [hyphal mass 127.9 mg (d y weigh )] g own in MEM cul u e medium we e supplemen ed wi h ampho e icin B a inal concen a- ions o 0.16 o 0.32 ìgml 1and g own o a u he 24 h. Hyphae we e ha es ed, washed wi h PBS and esuspended in esh medium o 24 h in he absence o ampho e icin B. The hyphal mass o he cul u e supplemen ed wi h 0.16 ìg ampho e icin B ml1had inc eased o 155.4 mg (d y weigh ) while ha o he cul u e supplemen ed wi h ampho e icin B a a concen a ion o 0.32 ìgml 1was 111.6 mg (d y weigh ). This inding indica es ha ampho e icin B a 0.16 ìgml 1does no p e en subsequen g ow h o he cul u e, and ha he 0.32 ìgml 1ampho e icin B ea men does no cause wide-scale hyphal cell dea h, as he d y weigh was s ill 87 % o he un ea ed con ol. The e ec o ampho e icin B on elease o in acellula cons i uen s om A. umiga us I has been es ablished p e iously ha ampho e icin B can induce he elease o in acellula cons i uen s om pa ho- genic ungi (Ghosh & Ghosh, 1963; Cohen, 1998). We sough o es ablish whe he his occu ed in A. umiga us and o de e mine whe he i con ibu ed o he enhanced elease o low molecula mass compounds. Se en y- wo-hou -old cul u es o A. umiga us we e exposed o ampho e icin B a inal concen a ions o 0.04, 0.08, 0.16 o 0.32 ìgml 1o 0.5 % ( / ) DMSO o 1, 2 o 4 h and he elease o amino acids and p o ein was moni o ed. DMSO was employed he e as a posi i e con ol since i is known o al e he pe meabili y o he cell memb ane (Yu & Quinn, 1998). The esul s show ha exposu e o 0.16 o 0.32 ìg ampho e icin B ml1o 0.5 % DMSO o pe iods o 2 o 4 h lead o he elease o ele a ed le els o amino acids compa ed o he ele an con ols (Fig. 2). In he case o exposu e o A. umiga us o 0.32 ìg ampho e icin B ml1 o 4 h, 2.741 0.069 ìg amino acid (mg hyphae)1was eleased. Hyphal mass [mg (25 ml cul u e)–1] Time (h) 0 5 10 15 20 25 30 35 40 45 024487296 Fig. 1. E ec o ampho e icin B on he g ow ho A. umiga us .Cul u e medium was supplemen ed wi h ampho e icin B p io o inocula ion wi h A. umiga us conidia. d, Con ol; s,0 .4; j,0 .08; h,0 .16; n, 0.32 ìg ampho e icin B ml1. The hyphal mass was de e mined a 24 h in e als. Ampho e icin B (µg ml–1) Amino acids [∝ g (mg hyphae)–1] 0 0·5 1 1·5 2 2·5 3 Con 0·04 0·08 0·16 0·32 DMSO Con 0·04 0·08 0·16 0·32 DMSO Con 0·04 0·08 0·16 0.32 DMSO 1 h 2 h 4 h ** * * ** * * * Fig. 2. E ec o ampho e icin B on elease o amino acids om hyphae o A. umiga us . Cul u es o A. umiga us we e supplemen ed wi h ampho e icin B and he elease o amino acids was assessed using he ninhyd in assay. DMSO was used as a posi i e con ol a a concen a ion o 0.5 % ( / ). *, S a is ically signi ican ( P ,0.05) di e ence compa ed o he ele an con ol. Ampho e icin-B-media ed elease o glio oxin om A. umiga us h p://jmm.sgmjou nals.o g 3 Enhanced p o ein elease om A. umiga us was also e iden a e exposu e o ampho e icin B o 2 o 4 h (Fig. 3). In his case he g ea es elease occu ed when 0.32 ìg ampho e icin Bml 1was employed o 4 h (35.57 2.56). Release o glio oxin om A. umiga us exposed o ampho e icin B Ampho e icin B can induce he elease o amino acids and p o ein om cul u es o A. umiga us o e a ela i ely sho ime pe iod (Figs 2 and 3). Since glio oxin is a low molecula mass dipep ide i could escape om A. umiga us in he same manne as amino acids and p o eins. Cul u es o A. umiga us which had been g own o a pe iod o 72 h o a hyphal mass o 29 mg we e supplemen ed wi h ampho e icin B a inal concen a ions o 0.04, 0.08, 0.16 o 0.32 ìgml 1and he amoun o glio oxin in he cul u e il a es was assessed a a ious ime poin s a e he addi ion. A e 1 h, he con ol cul u e demons a ed a glio oxin concen a ion o 210.336.1 ng (mg hyphae)1(Fig. 4). Those cul u es supplemen ed wi h 0.16 o 0.32 ìg ampho e icin B ml1 showed ele a ed le els o glio oxin in he cul u e supe - na an s, pa icula ly a e 2 and 4 h. The highes concen a- ion o glio oxin [506.624.7 ng (mg hyphae)1] was de ec ed in he cul u e supplemen ed wi h 0.32 ìg ampho- e icin B ml1a e 2 h incuba ion (Fig. 4). E ec o DMSO on glio oxin elease by A. umiga us Ampho e icin B unc ions by binding e gos e ol in he ungal cell memb ane and c ea ing po es h ough which in acellu- la cons i uen s may escape (Abu-Salah, 1996). I was pos ula ed ha he ele a ed le els o glio oxin obse ed in ampho e icin-B-supplemen ed cul u es could be due o he inc eased pe meabili y o he ungal cell memb ane. To es his hypo hesis 72-h-old cul u es o A. umiga us we e supplemen ed wi h DMSO, which also has he abili y o al e he pe meabili y o cell memb anes, bu in a di e en manne o ampho e icin B (Yu & Quinn, 1998). The esul s demon- s a ed a signi ican inc ease in glio oxin in he cul u e medium a e 2 h in hose cul u es supplemen ed wi h 0.5 % DMSO (Fig. 5). Following 4 h exposu e o DMSO, he glio oxin concen a ion in he cul u e medium supple- men ed wi h 0.5 % DMSO eached a alue o 431.14 23.1 ng (mg hyphae)1. Examina ion o in acellula and ex acellula concen a ion o glio oxin ollowing exposu e o A. umiga us o ampho e icin B o DMSO The ele a ed le els o glio oxin in ampho e icin-B- o DMSO-supplemen ed cul u es may be due o inc eased memb ane pe meabili y. Al e na i ely, he wo agen s could exe a ungis a ic e ec and his migh , in u n, lead o he inc eased syn hesis o seconda y me aboli es such as glio ox- in. To asce ain whe he his was he case he glio oxin concen a ion in supplemen ed medium and in he hyphae o A. umiga us was de e mined. In his case cul u es we e g own o 48 h and hen supplemen ed wi h he ele an concen a ion o ampho e icin B o DMSO o a u he 24 h. The esul s e ealed enhanced le els o glio oxin in he hyphae as well as in he cul u e medium o hose cul u es supplemen ed wi h ampho e icin B o DMSO (Fig. 6). The in a-hyphal glio oxin concen a ion in he cul u e Ampho e icin B (µg ml–1) P o ein [∝ g (mg hyphae)–1] Con 0·04 0·08 0·16 0·32 DMSO Con 0·04 0·08 0·16 0·32 DMSO Con 0·04 0·08 0·16 0·32 DMSO 0 5 10 15 20 25 30 35 40 45 1 h 2 h 4 h * * ** * * * ** * * * * * * Fig. 3. P o ein elease om A. umiga us ollowing exposu e o ampho e icin B. Cul u es we e supplemen ed wi h ampho e icin B and he elease o p o ein om hyphae was measu ed. DMSO was used as a posi i e con ol a a concen a ion o 0.5 % ( / ). *, S a is ically signi ican ( P ,0.05) di e ence compa ed o he ele- an con ol. Ampho e icin B (µg ml–1) Glio oxin [ng (mg hyphae) –1 ] 1 h 2 h 4 h 0 100 200 300 400 500 600 Con 0·04 0·08 0·16 0·32 Con 0·04 0·08 0·16 0·32 Con 0·04 0·08 0·16 0·32 * * * * *** Fig. 4. Release o glio oxin om A. umiga us cul u es supplemen ed wi h ampho e icin B. The concen a ion o glio oxin in ampho e icin-B- supplemen ed cul u es was assessed by HPLC analysis. *, S a is ically signi ican ( P ,0.05) di e ence compa ed o he ele an con ol. E. P. Ree es and o he s 4 Jou nal o Medical Mic obiology 53 supplemen ed wi h 0.16 ìg ampho e icin B ml1was 732.1 37.9ngmg 1compa ed o he con ol which showed a glio oxin concen a ion o 88.64.9ngmg 1. Simila ly, he glio oxin concen a ion in he MEM cul u e medium was 273.511.9ngml 1compa ed o 146.14.5ngml 1in he con ol. In he case o he cul u es supplemen ed wi h 0.5 % ( / ) DMSO, he glio oxin concen a ion in he cul u e medium was 227 12.1ngml 1(con ol: 146.114.5 ng ml1) while ha in he hyphae was ound o be 405.520.2ngmg 1compa ed o 88.64.9ngmg 1in he ele an con ol. In he case o A. umiga us g own in RPMI medium (Fig. 6) he ex acellula glio oxin concen a- ion was 39.47 1.2ngml 1in he con ol whe eas i was 205.19 8.2ngml 1when he cul u e was supplemen ed wi h ampho e icin B a a inal concen a ion o 0.16 ìgml 1. The in acellula glio oxin concen a ion inc eased om 3.63 0.13 ng (mg hyphae)1in he con ol o 41.4 0.74 ng (mg hyphae)1in he ampho e icin-B- ea ed cul- u e. Al hough di e en le els o glio oxin we e p oduced by A. umiga us in MEM and RPMI cul u e media, he abili y o ampho e icin B o inc ease he in acellula and ex acellula glio oxin le els was obse ed in cul u es g own in bo h media. DISCUSSION In ec ion by A. umiga us is a se ious h ea o he heal h o pa ien s immunocomp omised as a esul o disease, pul- mona y mal unc ion o medical he apy (Daly & Ka anagh, 2001) and, in he case o IA, may ha e a mo ali y a e o 85– 90 % (Denning, 1996b). Pa o he abili y o A. umiga us o colonize he lung is i s capaci y o supp ess he local immune esponse (Hogan e al., 1996). This can be achie ed h ough he ac ion o oxins and enzymes, and he abili y o glio oxin o acili a e coloniza ion is well cha ac e ized (Su on e al., 1995 & 1996). Glio oxin may supp ess he unc ion o pulmona y mac ophages and also a ec he gene al immune esponse o pa hogens by des oying cells o he spleen and he immune sys em (Su on e al., 1994). One o he p incipal d ugs used o comba aspe gillosis is he polyene ampho e icin B, which c ea es po es in he ungal cell memb ane h ough which in acellula cons i uen s escape (Abu-Salah, 1996; Cohen, 1998). I was pos ula ed ha such po es migh also se e o allow glio oxin o escape om he hyphae o A. umiga us, which could exace ba e glio oxin-media ed damage o pulmona y issue and he supp ession o he immune esponse in he in ec ed pa ien . As a consequence we sough o de e mine he esponse o hyphae o A. umiga us o ampho e icin B in e ms o he syn hesis and elease o glio oxin. Using ungis a ic concen a ions o ampho e icin B (Fig. 1) i was es ablished ha exposu e o cul u es o A. umiga us o ampho e icin B inc eased he elease o amino acids (Fig. 2) and p o ein (Fig. 3) 2–4 h a e addi ion. These inding sugges ed ha ampho e icin B was inducing he elease o in acellula cons i uen s om he ungal hyphae, possibly h ough he c ea ion o po es in he cell memb ane. Ele a ed 1 h 4 h 2 h Glio oxin [ng (mg hyphae) –1 ] 0 50 100 150 200 250 300 350 400 450 500 DMSO (%) Con 0·25 0·5 1·0 Con 0·25 0·5 1·0 Con 0·25 0·5 1·0 * * * * * * * Fig. 5. E ec o DMSO on elease o glio oxin om A. umiga us . Cul u es o A. umiga us we e supplemen ed wi h DMSO and he elease o glio oxin o e a 4 h pe iod was assessed by HPLC analysis. *, S a is ically signi ican ( P ,0.05) di e ence compa ed o he ele an con ol. 0 50 100 150 200 250 300 MEM AmpB (0·08µg ml–1) MEM Con ol MEM AmpB (0·16µg ml–1) MEM DMSO (0·5%) 0 100 200 300 400 500 600 700 800 900 RPMI AmpB (0·16µg ml–1) RPMI Con ol * * * * + + + + Ex acellula glio oxin [ng (ml cul u e)–1] In acellula glio oxin [ng (mg hyphae)–1] Fig. 6. In a- and ex acellula concen a ion o glio oxin in cul u es supplemen ed wi h ampho e icin B o DMSO. Cul u es o A. umiga us we e supplemen ed wi h ampho e icin B (0.08 o 0.16 ìgml 1)o DMSO (0.5 % / ). Ex acellula (open ba s) and in acellula ( illed ba s) glio oxin was ex ac ed and quan i ied by HPLC. S a is ically signi ican di e ences ( P ,0.05) compa ed o he ele an con ols a e indica ed by * o +. Ampho e icin-B-media ed elease o glio oxin om A. umiga us h p://jmm.sgmjou nals.o g 5 le els o glio oxin we e also de ec ed in media o cul u es supplemen ed wi h ampho e icin B (Fig. 4) o DMSO (Fig. 5). DMSO is commonly used as a sol en in biological science and can al e cell pe meabili y by a ec ing he s uc u e and in e ac ion o lipids in memb anes (Yu & Quinn, 1998; Go deliy e al., 1998) which may explain he elease o amino acids, p o ein and glio oxin obse ed he e. Gi en he p e iously es ablished abili y o ampho e icin B o induce he elease o in acellula cons i uen s om C. albicans (Ghosh & Ghosh, 1963), i appea ed ha his mechanism migh also be ope a ing he e o acili a e he elease o glio oxin. Howe e , when he in acellula con- cen a ion o glio oxin was asce ained i was ound o be ele a ed, along wi h aised le els de ec ed in he cul u e supe na an . In he case o MEM cul u es supplemen ed wi h 0.08 o 0.16 ìg ampho e icin B ml1, he in acellula concen a ion o glio oxin ose om 88.64.9ngmg 1 o 217.38 18.8ngmg 1and 732.137.9ngmg 1, espec- i ely (Fig. 6). This e ec was also appa en in RPMI-g own cul u es o A. umiga us. The inc eased concen a ion o glio oxin in cul u e supe - na an may be explained by he well es ablished abili y o ampho e icin B o inc ease he pe meabili y o he ungal cell memb ane ia he c ea ion o po es (Ghosh & Ghosh, 1963; Cohen, 1998). Howe e , he ele a ed le el o in acellula glio oxin could also con ibu e o he highe le els de ec ed in he cul u e. The abili y o ampho e icin B o inc ease he syn hesis o glio oxin may be media ed h ough i s ungi- s a ic abili ies. When applied o cul u es o C. albicans, ampho e icin B hal s eplica ion bu he cells emain iable (Liao e al., 1999) and he ungus may eco e he abili y o di ide in he absence o he polyene. Hal ing he cell’s g ow h may o ce he p oduc ion o seconda y me aboli es such as glio oxin. In e ec ampho e icin B may ha e wo dis inc e ec s on he ungal cell: (i) The ungis a ic e ec may hal eplica ion, lea ing he cell ali e bu capable o syn hesizing seconda y me aboli es such as glio oxin; (ii) The abili y o he polyene o c ea e ape u es in he ungal cell memb ane allows he escape o small molecula mass compounds, including glio oxin. The consequence o ampho e icin B exposu e a he cellula le el would be ele a ed syn hesis and elease, ia memb ane ape u es, o glio oxin. Al hough DMSO has a di e en p ima y e ec on cell memb anes (Yu & Quinn, 1998), i also induces ele a ed syn hesis and elease o glio oxin. In he case o exposu e o A. umiga us o DMSO, he ele a ed le els o glio oxin in he supe na an may be due o he inc eased pe meabili y o he ungal cell memb ane. The leakage o me aboli es may hinde he cell’s abili y o di ide, empo a ily allowing i syn hesize seconda y me aboli es such as glio oxin. The wo k p esen ed he e indica es ha when exposed o ampho e icin B in i o A. umiga us p oduces and sec e es he immunosupp essi e agen glio oxin a an ele a ed a e. Ampho e icin B he apy has many undesi able side e ec s (Cohen, 1998) and new o mula ions a e designed o minimize he oxici y owa ds hos issue (Ha sel & Bola d, 1996). Apa om i s di ec e ec on he hos , ampho e icin B may also induce he syn hesis and elease o seconda y me aboli es by A. umiga us which may con ibu e o g ea e pulmona y damage and dec eased immune unc ion bo h locally and sys emically. While he wo k p esen ed he e examined he esponse o A. umiga us o ampho e icin B in an in i o model, in i o e alua ion o his phenomenon may be equi ed o ully assess i s clinical signi icance. Recen wo k has indica ed ha ungi can su i e exposu e o ela i ely high le els o ampho e icin B, main ain ce ain cellula unc ions and po en ially esume eplica ion (Liao e al., 1999). This s udy has es ablished ha ampho e icin B may induce he syn hesis and elease o glio oxin om A. umiga us. This phenomenon has he po en ial o con ibu e o ele a ed le els o pulmona y damage (Eichne e al., 1986; Su on e al., 1996) and immunosupp ession (Su on e al., 1994, 1995) associa ed wi h his oxin. ACKNOWLEDGEMENTS This wo k was conduc ed independen ly o any pha maceu ical company wi h in e es s in an i- ungal d ug de elopmen o ma ke ing. This wo k was suppo ed by unding om he Highe Educa ion Au ho i y h ough PTRLI 3. REFERENCES Abu-Salah, K. M. (1996). Ampho e icin B: an upda e. B i J Biomed Sci 53, 122–133. Ami ani, R., Mu ayama, T., Nawada, R., Lee, W. J., Niimi, A., Suzuki, K., Tanaka, E. & Kuze, F. (1995a). Aspe gillus cul u e il a es and spu um sols om pa ien s wi h pulmona y aspe gillosis cause damage o human espi a o y cilia ed epi helium in i o. Eu Respi J 8, 1681–1687. Ami ani, R., Taylo , G., Elezis, E.-N., Llewellyn-Jones, C., Mi chell, J., Kuze, F., Cole, P. J. & Wilson, R. (1995b). Pu i ica ion and cha ac e iza- ion o ac o s p oduced by Aspe gillus umiga us which a ec human cilia ed espi a o y epi helium. In ec Immun 63, 3266–3272. Be ou , S., Badoc, C., Mallie, M., Giamimis, J. & Bas ide, J. M. (2002). Spo e di usa e isola ed om some s ains o Aspe gillus umiga us inhibi s phagocy osis by mu ine al eola mac ophages. FEMS Immunol Med Mic obiol 33, 101–106. B ai hwai e, A. W., Eichne , R. D., Wa ing, P. & Mullbache , A. (1987). The immunomodula ing agen glio oxin causes genomic DNA ag- men a ion. Mol Immunol 24, 47–55. Canu o, M. M. & Rode o, F. G. (2002). An i ungal d ug esis ance o azoles and polyenes. Lance (In ec Dis) 2, 550–563. Cohen, B. E. (1998). Ampho e icin B oxici y and le hali y: a ale o wo channels. In J Pha m 162, 95–106. Daly, P. & Ka anagh, K. (2001). Pulmona y aspe gillosis: clinical p esen a ion, diagnosis and he apy. B J Biomed Sci 58,197–205. Denning, D. W. (1996a). Aspe gillosis: diagnosis and ea men . In J An imic ob Agen s 6, 161–168. Denning, D. W. (1996b). The apeu ic ou come in in asi e aspe gillosis. Clin In ec Dis 23, 608–615. Denning, D. W. (1998). In asi e aspe gillosis. Clin In ec Dis 26, 781–805. Eichne , R. D., Al Salami, M., Wood, P. R. & Mullbache , A. (1986). The e ec o glio oxin upon mac ophage unc ion. In J Immunopha macol 8, 789–797. E. P. Ree es and o he s 6 Jou nal o Medical Mic obiology 53 Ellis, D. (2002). Ampho e icin B: spec um and esis ance. J An imic ob Chemo he 49, 7–10. F ase , R. S. (1993). Pulmona y aspe gillosis: pa hologic and pa hoge- ne ic ea u es. Pa hol Annu 28, 231–277. Ghosh, A. & Ghosh, J. J. (1963). Release o in acellula cons i uen s o Candida albicans in p esence o polyene an ibio ics. Ann Biochem Exp Med 23, 611–626. Go deliy, V. I., Kisele , M. A., Lesieu , P., Pole, A. V. & Teixei a, J. (1998). Lipid memb ane s uc u e and in e ac ions in dime hyl sul oxide/wa e mix u es. Biophys J 75, 2343–2351. Ha sel, S. & Bola d, J. (1996). Ampho e icin B: new li e o an old d ug. T ends Pha macol Sci 17, 445–449. Hogan, L. H., Klein, B. S. & Le i z, S. M. (1996). Vi ulence ac o s o medically impo an ungi. Clin Mic obiol Re 9, 469–488. Liao, R. S., Rennie, R. P. & Talbo , J. A. (1999). Assessmen o he e ec o ampho e icin B on he i ali y o Candida albicans.An imic ob Agen s Chemo he 43, 1034–1041. Pi a, T. J. (1994). Glio oxin induces apop osis in mouse L929 ib oblas cells. Biochem Mol Biol In 33, 411–419. Richa d, J. L. & DeBey, M. C. (1995). P oduc ion o glio oxin du ing pa hogenic s a e in u key poul s by Aspe gillus umiga us, F esenius. Mycopa hologia 129, 111–115. Richa d, J. L., D o ak, T. J. & Ross, P. F. (1996). Na u al occu ence o glio oxin in u keys in ec ed wi h Aspe gillus umiga us, F esenius. Mycopa hologia 134, 167–170. Shah, D. T., Glo e , D. D. & La sen, B. (1995). In si u myco oxin p oduc ion by Candida albicans in women wi h agini is. Gynecol Obs e In es 39, 67–69. Su on, P., Newcombe, N. R., Wa ing, P. & Mullbache , A. (1994). In i o immunosupp essi e ac i i y o glio oxin, a me aboli e p oduced by human pa hogenic ungi. In ec Immun 62, 1192–1198. Su on, P., Mo eland, A., Hu chinson, I. V. & Mullbache , A. (1995). In es iga ion o he po en ial use o immunosupp essi e agen glio oxin in o gan ansplan a ion. T ansplan a ion 60, 900–902. Su on, P., Wa ing, P. & Mullbache , A. (1996). Exace ba ion o in asi e aspe gillosis by he immunosupp essi e ungal me aboli e, glio oxin. Immunol Cell Biol 74, 318–322. Venegas, B., Gonzalez-Damian, J., Celis, H. & O ega-Blake, I. (2003). Ampho e icin B channels in he bac e ial memb ane: ole o s e ol and empe a u e. Biophys J 85, 2323–2332. Wa ing, P. (1990). DNA agmen a ion induced in mac ophages by glio oxin does no equi e p o ein syn hesis and is p eceded by aised inosi ol iphospha e le els. J Biol Chem 265, 14476–14480. Wa ing, P. & Bea e , J. (1996). Glio oxin and ela ed epipoly hiodiox- opipe azines. Gen Pha macol 27, 1311–1316. Yu, Z. W. & Quinn, P. J. (1998). Sol a ion e ec s o dime hyl sulphoxide on he s uc u e o phospholipid bilaye s. Biophys Chem 70, 35–39. Ampho e icin-B-media ed elease o glio oxin om A. umiga us h p://jmm.sgmjou nals.o g 7 O p in O de Fo m JMM Jou nal o Medical Mic obiology PAPER Please quo e his numbe in any co espondence Au ho s Da e I would like 25 ee o p in s, plus addi ional o p in s, gi ing a o al o o p in s Dispa ch add ess o o p in s (BLOCK CAPITALS please) Please comple e his o m e en i you do no wan ex a o p in s. Do no delay e u ning you p oo s by wai ing o a pu chase o de o you o p in s: he o p in o de o m can be sen sepa a ely. Please pay by c edi ca d o cheque wi h you o de i possible. Al e na i ely, we can in oice you. All emi ances should be made payable o ‘Socie y o Gene al Mic obiology’ and c ossed ‘A/C Payee only’. Tick one Cha ge my c edi ca d accoun (gi e ca d de ails below) I enclose a cheque/d a payable o Socie y o Gene al Mic obiology Pu chase o de enclosed Re u n his o m o: JMM Edi o ial O ice, Ma lbo ough House, Basings oke Road, Spence s Wood, Reading RG7 1AG, UK. PAYMENT BY CREDIT CARD (No e: we canno accep Ame ican Exp ess) Please cha ge he sum o £ o my c edi ca d accoun . My Access/Eu oca d/Mas e ca d/Visa numbe is (ci cle app op ia e ca d; no o he s accep able): Signa u e: Da e: Ca dholde ’s name and add ess*: *Add ess o which you c edi ca d s a emen is sen . You o p in s will be sen o he add ess shown a he op o he o m. OFFICE USE ONLY Issue: Vol/pa : Page nos: Ex en : P ice: In oice: JR/ Ap il 2003 Expi y da e CHARGES FOR ADDITIONAL OFFPRINTS Copies 25 50 75 100 125 150 175 200 Pe 25 ex a No. o pages 1–2 £21 £37 £53 £69 £85 £101 £117 £133 £21 3–4 £32 £53 £74 £95 £117 £138 £159 £175 £27 5–8 £42 £69 £95 £122 £148 £175 £201 £228 £32 9–16 £53 £85 £117 £148 £180 £212 £244 £276 £37 17–24 £64 £101 £138 £175 £212 £249 £286 £323 £42 each 8pp ex a £16 £21 £27 £32 £37 £42 £48 £53